Pfizer Inc PFE:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 01/27/23 EST

43.89

+0.10 (+0.23%)

Volume

2,002,893

43.79

-0.46 (-1.04%)

Volume

21,601,111

52 week range

41.44 - 56.32

Open44.22
Day High44.34
Day Low43.78
Prev Close44.25
52 Week High56.32
52 Week High Date04/11/22
52 Week Low41.44
52 Week Low Date10/11/22

Key Stats

Market Cap245.807B
Shares Out5.61B
10 Day Average Volume25.47M
Dividend1.64
Dividend Yield3.75%
Beta0.63
YTD % Change-14.54

KEY STATS

Open44.22
Day High44.34
Day Low43.78
Prev Close44.25
52 Week High56.32
52 Week High Date04/11/22
52 Week Low41.44
52 Week Low Date10/11/22
Market Cap245.807B
Shares Out5.61B
10 Day Average Volume25.47M
Dividend1.64
Dividend Yield3.75%
Beta0.63
YTD % Change-14.54

RATIOS/PROFITABILITY

EPS (TTM)5.27
P/E (TTM)8.31
Fwd P/E (NTM)10.41
EBITDA (TTM)42.501B
ROE (TTM)35.91%
Revenue (TTM)99.676B
Gross Margin (TTM)65.51%
Net Margin (TTM)30.35%
Debt To Equity (MRQ)39.59%

EVENTS

Earnings Date01/31/2023
Ex Div Date01/26/2023
Div Amount0.41
Split Date-
Split Factor-

Latest On Pfizer Inc

Cramer’s week ahead: Fed decision on Wednesday could let the bulls ‘party on’14 Hours AgoCNBC.com
Cheap quality stocks offer a smoother ride, according to Trivariate Research21 Hours AgoCNBC.com
Stocks making the biggest moves midday: Chevron, Tesla, United Rentals and moreJanuary 26, 2023CNBC.com
FDA doesn't see higher risk of stroke for seniors after Pfizer omicron booster January 26, 2023CNBC.com
Thursday, Jan. 26, 2023: Cramer says buy this stock whenever you get the chanceJanuary 26, 2023CNBC.com

Content From Our Affiliates

FDA advisors recommend replacing original COVID-19 vaccine, CNBC reportsJanuary 27, 2023TipRanks
UBS downgrades Pfizer, says COVID estimates need to dropJanuary 26, 2023TipRanks
Pfizer downgraded to Neutral from Buy at UBSJanuary 26, 2023TipRanks
Biohaven initiated with an Outperform at SVB SecuritiesJanuary 24, 2023TipRanks
Pharma Industry Could Benefit from Rise in Medicine SpendingJanuary 24, 2023TipRanks

Profile

Pfizer Inc. is a research-based biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. The Company operations through two segments: Biopharma and PC1. Biopharma is a science-based medicines business that includes six therapeutic areas, such as Vaccines, Hospital, Oncology, Internal Medicine, Rare Disease, and Inflammation & Immunology. PC1 is its global...

Albert Bourla Ph.D.

Chairman of the Board, Chief Executive Officer

David Denton

Executive Vice President, Chief Financial Officer

Aamir Malik

Executive Vice President, Chief Business Innovation Officer

Lidia Fonseca Ph.D.

Executive Vice President, Chief Digital and Technology Officer

Douglas Lankler

Executive Vice President, General Counsel

Address

235 E 42ND ST

New York, NY

10017-5703

United States

https://www.pfizer.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
RHHBY Roche Holding